Portfolio

ProNAi Therapeutics, Inc.

 

ProNAi Therapeutics, Inc.

ProNAi Therapeutics, Inc. is a pharmaceutical therapy development company. ProNAi has a novel and proprietary nucleic acid-based interfering technology on which it is developing a new generation of therapies for patients with cancer and other diseases.  With promising clinical data, Pronai closed the largest VC round in Michigan history.  Amherst Fund is an equity investor in ProNAi.

 

Website:

www.pronai.com